Medtronic (MDT) Share-based Compensation (2014 - 2026)

Medtronic (MDT) has 13 years of Share-based Compensation data on file, last reported at $95.0 million in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 6.74% year-over-year to $95.0 million; the trailing twelve-month figure through Apr 2026 stood at $457.0 million (up 6.53% YoY), and the FY2026 full-year result was $457.0 million, up 6.53% from the prior year.
• Share-based Compensation advanced to $95.0 million in Q2 2026, from $94.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $182.0 million in Q4 2025 to a low of $62.0 million in Q3 2022.
• A 5-year average of $99.2 million and a median of $87.5 million in 2025 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 20.0% in 2022, while the deepest fall reached 10.14% in 2022.
• Tracing MDT's Share-based Compensation over 5 years: stood at $137.0 million in 2022, then grew by 6.57% to $146.0 million in 2023, then advanced by 8.9% to $159.0 million in 2024, then advanced by 14.47% to $182.0 million in 2025, then sank by 47.8% to $95.0 million in 2026.
• Business Quant data shows MDT's Share-based Compensation at $95.0 million in Q2 2026, $94.0 million in Q1 2026, and $182.0 million in Q4 2025.